NetworkNewsBreaks – Brain Scientific Inc. (BRSF)
Post# of 129
(Total Views: 172)
Posted On: 11/03/2020 2:52:56 PM
NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Appoints Experienced Innovator as VP of Strategy
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has announced the appointment of a new vice president of strategy and business development. In her new role, Amy Griffith will be responsible for the company’s development of strategic and tactical initiatives, as well as new sales strategies. A veteran sales and innovation expert, Griffith has held executive management positions at leading technology companies and has also worked with start-ups, focusing on identifying and implementing strategic sales programs. With an expertise in the medical and health-care industry, Griffith has been deeply involved and brings impressive experience in strategic planning and relationship building, market expansion, contract negotiation, and competitive intelligence. Her work at GlaxoSmithKline involved promoting a product portfolio to several hundred psychiatrists, neurologists, internists, OB/GYN and family practice physicians. “We are excited to have Amy on our team,” said Brain Scientific chairman Boris Goldstein in the press release. “She has been consistently awarded for goal-exceeding performance throughout her extensive career. Ms. Griffith has an exceptional knowledge of the neurology market and has the expertise to implement sales processes that drive revenue and enhance market share,”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has announced the appointment of a new vice president of strategy and business development. In her new role, Amy Griffith will be responsible for the company’s development of strategic and tactical initiatives, as well as new sales strategies. A veteran sales and innovation expert, Griffith has held executive management positions at leading technology companies and has also worked with start-ups, focusing on identifying and implementing strategic sales programs. With an expertise in the medical and health-care industry, Griffith has been deeply involved and brings impressive experience in strategic planning and relationship building, market expansion, contract negotiation, and competitive intelligence. Her work at GlaxoSmithKline involved promoting a product portfolio to several hundred psychiatrists, neurologists, internists, OB/GYN and family practice physicians. “We are excited to have Amy on our team,” said Brain Scientific chairman Boris Goldstein in the press release. “She has been consistently awarded for goal-exceeding performance throughout her extensive career. Ms. Griffith has an exceptional knowledge of the neurology market and has the expertise to implement sales processes that drive revenue and enhance market share,”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Brain Scientific, Inc. (BRSF) Stock Research Links
Scroll down for more posts ▼